In Brief
This article was originally published in The Tan Sheet
Executive Summary
Hi-Tech OTCs up slightly in fiscal 2013; Pharmstandard spins off OTC unit; Nu Skin raises estimates; infant formula makers respond to China inquiry; Pennsylvania joins NPLEx; and Everett alleges Acella infringes in prenatals.